f**********g
发帖数: 2252 | 1 anyone familar?
Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
on Tuesday, March 1
1 days 6 hours 27 minutes ago - EUR via Comtex
PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
with operations in the U.S. and China, announced today that Dr. Robert
Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
, New York, NY. Dr. Preti will present as part of the Adult Stem Cell track
at 2:11 pm.
Dr. Preti is co-founder of Progenitor Cell Therapy, LLC, an internationally
recognized cell therapy services and development company. Through his
administrative duties, Dr. Preti has overseen the growth of PCT from its
inception to the world's leading commercial cell therapy company. He is one
of the country's leading authorities on cell engineering, advanced cell and
gene therapy manufacturing, testing and delivery, and regulatory aspects
relating to the cell therapy and regenerative medicine industry and has been
a pioneer of cell manufacturing as with Dendreon's product Provenge which
just received FDA approval in 2010. He has been the principal investigator
for a number of clinical trials relating to the clinical testing of cellular
therapies. Previous positions held by Dr. Preti include Scientific and
Laboratory Director of Hackensack University Medical Center's stem cell
processing and research laboratory and Scientific Director of the Clinical
Services Division at the New York Blood Center.
The Company acquired PCT in January 2011. PCT, through its cGMP certified
manufacturing facilities and team of professionals, facilitates the
preclinical and clinical development and eventual commercialization of
cellular therapies for clients in the United States and internationally.
Dr. Robert Preti said, "I am honored to be invited to be one of
approximately 35 scheduled leaders of the stem cell industry to speak at
this event. Progenitor Cell Therapy is a client-based cell therapy services
company that supports the development of cellular therapies. We have
extensive experience and expertise in having processed over 30,000 cell
therapy product procedures and shipped over 5,000 cell therapy products for
transplantation over the last ten years. The full range of our services for
cell therapy clients include consulting, product and process development,
processing, manufacturing, storage, and transport."
The New York Stem Cell Summit is organized and sponsored by Robin R. Young,
CFA, President of RRY Publications, LLC. According to the Summit's website,
the Summit "will bring the future of this dynamic industry to life for
investors, industry, practitioners, and analysts."
About NeoStem, Inc.
NeoStem, Inc. is an international biopharmaceutical company with adult stem
cell operations in the U.S., a network of adult stem cell therapeutic
providers in China as well as a 51% ownership interest in a profitable
Chinese generic pharmaceutical manufacturing company. NeoStem is focused on
accelerating the development of proprietary cellular therapies and becoming
a single source for collection, storage, manufacturing, therapeutic
development and transportation of cells for cell based medicine and
regenerative science globally. The Company also has licensed various
cellular therapy technologies, including worldwide exclusive licenses to a
wound healing technology and to VSEL(TM) Technology which uses very small
embryonic-like stem cells, which are adult stem cells that have been shown
to have several physical characteristics that are generally found in
embryonic stem cells.
For more information, please visit: http://www.neostem.com. | M***m
发帖数: 762 | 2 still hold.
Noticed that the CEO just bought some on Feb 28.
company
asked
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| p********e
发帖数: 1960 | 3 already set up a 1.70 selling price....maybe a little less ambitious....but
better than underwater...haha
【在 M***m 的大作中提到】
: still hold.
: Noticed that the CEO just bought some on Feb 28.
:
: company
: asked
: Street
| M***m
发帖数: 762 | 4 I am too greedy, half @ 1.95, h**[email protected]
but I do not know whether I can hold that long.
but
【在 p********e 的大作中提到】
: already set up a 1.70 selling price....maybe a little less ambitious....but
: better than underwater...haha
| y*****l
发帖数: 5997 | | f**********g
发帖数: 2252 | 6 这个最初是谁推荐的？为什么买？
我都忘了为什么在我的watch list上了。
【在 M***m 的大作中提到】
: still hold.
: Noticed that the CEO just bought some on Feb 28.
:
: company
: asked
: Street
| f**********g
发帖数: 2252 | | M***m
发帖数: 762 | 8 NBS will attend the Rodman and Renshaw conference on March 8, 2011. http://www.rodmanandrenshaw.com/conferences?id=61
【在 f**********g 的大作中提到】
: Good today.
| B*****e
发帖数: 2413 | 9 Just new bio-therapy concept for burning money. No clinical use in the
coming 10 years.
Summit
company
asked
Cell
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| B*****e
发帖数: 2413 | 10 Just new bio-therapy concept for burning money. No clinical use in the
coming 10 years.
Summit
company
asked
Cell
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| | | q********g
发帖数: 10694 | 11 为什么beta值这么低才0.5？是不是钱花不完？呵呵。
一直在1.4埋伏，不多4000shares。 | p********e
发帖数: 1960 | 12 冒一个泡，昨天调整的止赢到1.75...今天没时间，结果中午被收走在最低点，根据我
上两次ZLCS和BPAX的经验，此股必然再彪30%...哈哈
but
【在 p********e 的大作中提到】
: already set up a 1.70 selling price....maybe a little less ambitious....but
: better than underwater...haha
| p********e
发帖数: 1960 | | p********e
发帖数: 1960 | 14 filled at 1.50....sold at 1.69....
【在 p********e 的大作中提到】
: 等着1.4X重入...看能不能等得到了
| f**********g
发帖数: 2252 | 15 anyone familar?
Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
on Tuesday, March 1
1 days 6 hours 27 minutes ago - EUR via Comtex
PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
with operations in the U.S. and China, announced today that Dr. Robert
Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
, New York, NY. Dr. Preti will present as part of the Adult Stem Cell track
at 2:11 pm.
Dr. Preti is co-founder of Progenitor Cell Therapy, LLC, an internationally
recognized cell therapy services and development company. Through his
administrative duties, Dr. Preti has overseen the growth of PCT from its
inception to the world's leading commercial cell therapy company. He is one
of the country's leading authorities on cell engineering, advanced cell and
gene therapy manufacturing, testing and delivery, and regulatory aspects
relating to the cell therapy and regenerative medicine industry and has been
a pioneer of cell manufacturing as with Dendreon's product Provenge which
just received FDA approval in 2010. He has been the principal investigator
for a number of clinical trials relating to the clinical testing of cellular
therapies. Previous positions held by Dr. Preti include Scientific and
Laboratory Director of Hackensack University Medical Center's stem cell
processing and research laboratory and Scientific Director of the Clinical
Services Division at the New York Blood Center.
The Company acquired PCT in January 2011. PCT, through its cGMP certified
manufacturing facilities and team of professionals, facilitates the
preclinical and clinical development and eventual commercialization of
cellular therapies for clients in the United States and internationally.
Dr. Robert Preti said, "I am honored to be invited to be one of
approximately 35 scheduled leaders of the stem cell industry to speak at
this event. Progenitor Cell Therapy is a client-based cell therapy services
company that supports the development of cellular therapies. We have
extensive experience and expertise in having processed over 30,000 cell
therapy product procedures and shipped over 5,000 cell therapy products for
transplantation over the last ten years. The full range of our services for
cell therapy clients include consulting, product and process development,
processing, manufacturing, storage, and transport."
The New York Stem Cell Summit is organized and sponsored by Robin R. Young,
CFA, President of RRY Publications, LLC. According to the Summit's website,
the Summit "will bring the future of this dynamic industry to life for
investors, industry, practitioners, and analysts."
About NeoStem, Inc.
NeoStem, Inc. is an international biopharmaceutical company with adult stem
cell operations in the U.S., a network of adult stem cell therapeutic
providers in China as well as a 51% ownership interest in a profitable
Chinese generic pharmaceutical manufacturing company. NeoStem is focused on
accelerating the development of proprietary cellular therapies and becoming
a single source for collection, storage, manufacturing, therapeutic
development and transportation of cells for cell based medicine and
regenerative science globally. The Company also has licensed various
cellular therapy technologies, including worldwide exclusive licenses to a
wound healing technology and to VSEL(TM) Technology which uses very small
embryonic-like stem cells, which are adult stem cells that have been shown
to have several physical characteristics that are generally found in
embryonic stem cells.
For more information, please visit: http://www.neostem.com. | M***m
发帖数: 762 | 16 still hold.
Noticed that the CEO just bought some on Feb 28.
company
asked
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| p********e
发帖数: 1960 | 17 already set up a 1.70 selling price....maybe a little less ambitious....but
better than underwater...haha
【在 M***m 的大作中提到】
: still hold.
: Noticed that the CEO just bought some on Feb 28.
:
: company
: asked
: Street
| M***m
发帖数: 762 | 18 I am too greedy, half @ 1.95, h**[email protected]
but I do not know whether I can hold that long.
but
【在 p********e 的大作中提到】
: already set up a 1.70 selling price....maybe a little less ambitious....but
: better than underwater...haha
| y*****l
发帖数: 5997 | | f**********g
发帖数: 2252 | 20 这个最初是谁推荐的？为什么买？
我都忘了为什么在我的watch list上了。
【在 M***m 的大作中提到】
: still hold.
: Noticed that the CEO just bought some on Feb 28.
:
: company
: asked
: Street
| | | f**********g
发帖数: 2252 | | M***m
发帖数: 762 | 22 NBS will attend the Rodman and Renshaw conference on March 8, 2011. http://www.rodmanandrenshaw.com/conferences?id=61
【在 f**********g 的大作中提到】
: Good today.
| B*****e
发帖数: 2413 | 23 Just new bio-therapy concept for burning money. No clinical use in the
coming 10 years.
Summit
company
asked
Cell
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| B*****e
发帖数: 2413 | 24 Just new bio-therapy concept for burning money. No clinical use in the
coming 10 years.
Summit
company
asked
Cell
Street
【在 f**********g 的大作中提到】
: anyone familar?
: Progenitor Cell Therapy to Present at 6th Annual New York Stem Cell Summit
: on Tuesday, March 1
: 1 days 6 hours 27 minutes ago - EUR via Comtex
: PR Newswire EuropeNeoStem, Inc. , an international biopharmaceutical company
: with operations in the U.S. and China, announced today that Dr. Robert
: Preti, PhD, President and Chief Scientific Officer of Progenitor Cell
: Therapy ("PCT"), a wholly-owned subsidiary of NeoStem, Inc., has been asked
: to present on Tuesday, March 1, 2011 at the 6th Annual New York Stem Cell
: Summit. The Summit will be held at Bridgewaters New York at 11 Fulton Street
| q********g
发帖数: 10694 | 25 为什么beta值这么低才0.5？是不是钱花不完？呵呵。
一直在1.4埋伏，不多4000shares。 | p********e
发帖数: 1960 | 26 冒一个泡，昨天调整的止赢到1.75...今天没时间，结果中午被收走在最低点，根据我
上两次ZLCS和BPAX的经验，此股必然再彪30%...哈哈
but
【在 p********e 的大作中提到】
: already set up a 1.70 selling price....maybe a little less ambitious....but
: better than underwater...haha
| p********e
发帖数: 1960 | |
|
